Spero Therapeutics
SPRO
#9626
Rank
โ‚ฌ35.57 M
Marketcap
0,64ย โ‚ฌ
Share price
-0.29%
Change (1 day)
-52.03%
Change (1 year)

EPS for Spero Therapeutics (SPRO)

EPS in 2023 (TTM): -0,26ย โ‚ฌ

According to Spero Therapeutics's latest financial reports the company's current EPS (TTM) is -0,23ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,46ย โ‚ฌ an increase over its 2021 EPS that were of -2,55ย โ‚ฌ.

EPS history for Spero Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,26ย โ‚ฌ-81.89%
2022-1,46ย โ‚ฌ-42.96%
2021-2,55ย โ‚ฌ-19.39%
2020-3,17ย โ‚ฌ9.39%
2019-2,90ย โ‚ฌ25.48%
2018-2,31ย โ‚ฌ-51.35%
2017-4,74ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
1,16ย โ‚ฌ-607.69%๐Ÿ‡บ๐Ÿ‡ธ USA
6,69ย โ‚ฌ-3,030.77%๐Ÿ‡บ๐Ÿ‡ธ USA
4,36ย โ‚ฌ-2,012.27%๐Ÿ‡จ๐Ÿ‡ฆ Canada